ARCHIVES

“What Is Good For NCI Is Good For NIH,” Broder Says In Address

This article is from The Cancer Letter archive.

Vol. 21 No. 02 | January 13, 1995

Download PDF Visit The Full Archive

Related Articles

Multiple Studies Show Benefit of CTL019, A Personalized Therapy, in CLL and ALL

December 27, 2013

CMS also decided to cover off-label uses of approved colorectal cancer drugs in clinical trials, and allowed broader use of PET scans.

November 5, 2004

Smoking Cessation Training Follows Doctors Into Practice

October 29, 2004

Tobacco Control: Surgeon General Finds Increase In Smoking By Minority Teens

May 1, 1998

Senate Committee Passes Bill To Speed FDA Approval Of Follow-On Biologics.

June 29, 2007

DCPC Planning 10 More Prevention Fellowship Awards

August 14, 1987